Clinical Trials Browser

Adenocarcinoma Of Esophagus, Adenocarcinoma, Esophageal Neoplasms, Stomach Neoplasms

Colonic Neoplasms, Rectal Neoplasms

Pancreatic Neoplasms

Colorectal Neoplasms

Biliary Tract Neoplasms, Gallbladder Neoplasms, Cholangiocarcinoma

Rectal Neoplasms

Locally Advanced Gastric or Gastroesophageal Junction Cancer

Rectal Neoplasms

HER2-positive Gastric Cancer

Adenocarcinoma Of Esophagus

Colorectal Neoplasms

Clinical Stage I Esophageal Adenocarcinoma AJCC v8

Colorectal Neoplasms

Pancreatic Neoplasms

Adenocarcinoma, Neoplasms

Resectable Colon Cancer

Colorectal Neoplasms

Lymphoma, Large B-Cell, Diffuse

Colorectal Adenocarcinoma

Rectal Neoplasms

Stomach Neoplasms

Colorectal Neoplasms

Rectal Neoplasms

Neoplasms, Stomach Neoplasms

Stomach Neoplasms

Colorectal Neoplasms

First-line Treatment of Metastatic Pancreatic Cancer

Colorectal Neoplasms

Lymphoma, Large B-Cell, Diffuse

Colonic Neoplasms

Stomach Neoplasms

Neoplasm Metastasis, Neoplasms, Colorectal Neoplasms

Rectal Neoplasms

Colorectal Neoplasms

Neoplasm Metastasis, Pancreatic Neoplasms

Cholangiocarcinoma

Esophageal Squamous Cell Carcinoma

Lymphoma, Large B-Cell, Diffuse

Stomach Neoplasms

Carcinoma, Hepatocellular

Colorectal Neoplasms

First-line Treatment of Advanced Pancreatic Cancer

Stomach Neoplasms

Adenocarcinoma, Stomach Neoplasms

Carcinoma, Hepatocellular

Rectal Neoplasms

Adenocarcinoma, Stomach Neoplasms

Colorectal Neoplasms

Rectal Neoplasms

Clinical Trials

Sonesitatug Vedotin in Combination With Capecitabine With or Without Rilvegostomig in Participants With Advanced or Metastatic Gastric, Gastroesophageal Junction, or Esophageal Adenocarcinoma Expressing Claudin18.2

KANDLELIT-012

A Study to Evaluate the Effectiveness and Safety of Setidegrasib, Given With Either mFOLFIRINOX or NALIRIFOX Chemotherapies, in People With Pancreatic Cancer

Testing Pump Chemotherapy in Addition to Standard of Care Chemotherapy Versus Standard of Care Chemotherapy Alone for Patients With Unresectable Colorectal Liver Metastases: The PUMP Trial

Beacon-BTC

A Clinical Trial Comparing Long-Course Versus Short-Course Radiotherapy Followed by Immunotherapy Combined With Total Neoadjuvant Therapy (TNT) to Long-Course Radiotherapy Followed by TNT in Locally Advanced Rectal Cancer

Clinical Study of Adebrelimab Therapy in the Perioperative Treatment of Gastric Cancer or Gastroesophageal Junction Cancer

NEO-RT

A Phase Ⅲ Study of Rilvegostomig in Combination With Fluoropyrimidine and Trastuzumab Deruxtecan as the First-line Treatment for HER2-positive Gastric Cancer

mFOLFIRINOX Versus mFOLFOX With or Without Nivolumab for the Treatment of Advanced, Unresectable, or Metastatic HER2 Negative Esophageal, Gastroesophageal Junction, and Gastric Adenocarcinoma

OrigAMI-2

Comparing Proton Therapy to Photon Radiation Therapy for Esophageal Cancer

HARMONi-GI3

LAP100

LUCERNA

Neoadjuvant/Adjuvant AK104 in Microsatellite Instability-high or Mismatch Repair-deficient, Resectable Colon Cancer

MOUNTAINEER-03

A Phase III Study of HMPL-760 Plus R-GemOx VS Placebo Plus R-GemOx in Relapsed/Refractory DLBCL

AK112 and Chemotherapy in First-line Metastatic Colorectal Cancer

FOBEAR

A Phase Ⅲ Clinical Study of HLX22 in Combination With Trastuzumab and Chemotherapy for the Treatment of Gastroesophageal Junction and Gastric Cancer

CAPRI-3 GOIM

Preoperative FOLFOX Versus Postoperative Risk-adapted Chemotherapy in Patients With Locally Advanced Rectal Cancer

Adjuvant Oxaliplatin Plus S-1 Versus Docetaxel Plus S-1 for Stage III Gastric Cancer

A Study of Disitamab Vedotin Combined With Trastuzumab and Tislelizumab Versus Chemotherapy Combined With Trastuzumab With or Without Pembrolizumab in HER2-high Expression Advanced Gastric or Gastroesophageal Junction Adenocarcinoma.

AIO-KRK-0418

Irinotecan Hydrochloride Liposome Injection (II)in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Metastatic Pancreatic Cancer

AtezoTRIBE2

A Phase 3 Clinical Study of SHR-A1912 Combined With R-GemOx Versus R-GemOx in Diffuse Large B-cell Lymphoma

The Sagittarius Trial

Tislelizumab Plus FOLFOX Versus POF in the Treatment of Locally Advanced: a Multicenter, Open-label, Randomized Phase III Studyunresectable or Metastatic Gastric/Gastroesophageal Junction Adenocarcinoma

OSCAR

mRCAT-III

EFFIPEC

PANThEON

The Possible Protective Role of Ketotifen Against Oxaliplatin Induced Peripheral Neuropathy

Toripalimab Plus Lenvatinib and Gemcitabine-based Chemotherapy in 1L Treatment of Advanced ICC: a Phase III Study

NEEDS

Study Comparing BEBT-908 Combined With R to SOC for the Treatment of Relapsed/Refractory Diffuse Large B-Cell Lymphoma

PREVENT

HAIC

Circulating Tumor DNA Methylation Guided Postoperative Adjuvant Chemotherapy for High-risk Stage II/III Colorectal Cancer

HR070803 in Combination With Oxaliplatin, 5-FU/LV Versus AG for First-line Treatment of Advanced Pancreatic Cancer

Compare Adjuvant Chemotherapy of Docetaxel/Capecitabine/Oxliplatin Versus Capecitabine/Oxaliplatin in Advanced Gastric Cancer at Stage IIIb and IV(KCSG ST15-08): TRIUMPH

M108 Plus CAPOX Versus Placebo Plus CAPOX as First-line Treatment for Claudin (CLDN) 18.2-Positive, HER2-Negative, PD-L1 CPS<5, Locally Advanced Unresectable or Metastatic Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma.

FOLFOX-HAIC Plus Lenvatinib and Toripalimab vs. FOLFOX-HAIC Plus Lenvatinib for Advanced Hepatocellular Carcinoma: a Randomized Controlled and Double-blind Trial

Neoadjuvant Chemotherapy With PD-1 Inhibitors Combined With SIB-IMRT in the Treatment of Locally Advanced Rectal Cancer

Perioperative FLOT vs Adjuvant XELOX for CA Stomach

PACE: PD-1 Antibody For dMMR/MSI-H Stage III Colorectal Cancer

RCNAC